Klaus-Armin Nave
Has participated in:
-
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy
-
Sirt2 promotes white matter oligodendrogenesis during development and in models of neonatal hypoxia
-
Genetic and autoimmune modulators of brain function in neuropsychiatric illness and health
-
Survival of adult neurons lacking cholesterol synthesis in vivo